Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1176 participants
OBSERVATIONAL
2021-06-11
2023-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Safety and Satisfaction Toward COVID-19 Vaccines.
NCT05857176
COVID19 Vaccination: Clinical, Laboratory and Cellular Monitoring
NCT04844632
COVID-19 Vaccines Safety Tracking (CoVaST)
NCT04834869
Local and General Immune Response After Coronavirus Disease (COVID-19) Vaccination in Volunteers
NCT04996238
Immunization of 7 Different Vaccines Against SARS-COV-2 Across 4 Countries.
NCT05228912
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adults receiving COVID-19 vaccine
Adults about to receive a COVID-19 vaccine fill out a questionnaire of potential predictors of side effect occurrence
COVID-19 vaccine
Adults about to receive a COVID-19 vaccine fill out a questionnaire of potential predictors of side effect occurrence
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
COVID-19 vaccine
Adults about to receive a COVID-19 vaccine fill out a questionnaire of potential predictors of side effect occurrence
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants are also a part of the ENFORCE study from which outcome data is obtained
* Must be able to read and understand Danish
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Aarhus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lene Vase
Role: STUDY_CHAIR
University of Aarhus
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aarhus University
Aarhus, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AUvac
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.